Live feed
Filing
SC 13G
SC 13G0001535610-18-000071·Armata Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
AMPLIPHI BIOSCIENCES CORP
Security class unavailable · CUSIP: 03211P301
Event date: 2018-03-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 640,455
- Percent of class
- 3.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-18-000071
- Form type
- SC 13G
- Filer
- Armata Pharmaceuticals, Inc.
- CIK
- CIK 921114
- Filed
- Mar 22, 2018
- Reporting period
- Mar 20, 2018
- Description
- Schedule 13G beneficial ownership